Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Stroke

Poststroke cognitive impairment—what are we measuring?

Cognitive impairment is a major sequela after stroke. A recent study shows that cognitive impairment is prevalent after ischaemic stroke, even in patients with good functional recovery, and that compromise in different cognitive domains predicts future functional disability. Here, we reflect on how poststroke cognitive impairment is measured and conceptualized.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

References

  1. Jokinen, H. et al. Post-stroke cognitive impairment is common even after successful clinical recovery. Eur. J. Neurol. http://dx.doi.org/10.1111/ene.12743.

  2. Godefroy, O. et al. Validation of an integrated method for determining cognitive ability: implications for routine assessments and clinical trials. Cortex 54, 51–62 (2014).

    Article  Google Scholar 

  3. Farias, S. T., Harrell, E., Neumann, C. & Houtz, A. The relationship between neuropsychological performance and daily functioning in individuals with Alzheimer's disease: ecological validity of neuropsychological tests. Arch. Clin. Neuropsychol. 18, 655–672 (2003).

    Article  Google Scholar 

  4. Morris, J. C. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 43, 2412–2414 (1993).

    Article  CAS  Google Scholar 

  5. Cedarbaum, J. M. et al. Rationale for use of the Clinical Dementia Rating Sum of Boxes as a primary outcome measure for Alzheimer's disease clinical trials. Alzheimers Dement. 9 (1 Suppl.), S45–S55 (2013).

    Article  Google Scholar 

  6. Yang, J. et al. Risk factors for incident dementia after stroke and transient ischemic attack. Alzheimers Dement. 11, 16–23 (2015).

    Article  Google Scholar 

  7. Sperling, R. & Johnson, K. Biomarkers of Alzheimer disease: current and future applications to diagnostic criteria. Continuum (Minneap. Minn.) 19, 325–338 (2013).

    Google Scholar 

  8. Hachinski, V. et al. National Institute of Neurological Disorders and Stroke–Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke 37, 2220–2241 (2006).

    Article  Google Scholar 

  9. Amodio, D. M. & Frith, C. D. Meeting of minds: the medial frontal cortex and social cognition. Nat. Rev. Neurosci. 7, 268–277 (2006).

    Article  CAS  Google Scholar 

  10. Darby, D. G. et al. Intraindividual cognitive decline using a brief computerized cognitive screening test. Alzheimers Dement. 8, 95–104 (2012).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Adrian Wong.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wong, A., Mok, V. Poststroke cognitive impairment—what are we measuring?. Nat Rev Neurol 11, 487–488 (2015). https://doi.org/10.1038/nrneurol.2015.130

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneurol.2015.130

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing